Low nitric oxide: a key factor underlying copper-deficiency teratogenicity

Soo Jin Yang, Carl L Keen, Louise Lanoue, Robert B. Rucker, Janet Y. Uriu-Adams

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Copper (Cu)-deficiency-induced teratogenicity is characterized by major cardiac, brain, and vascular anomalies; however, the underlying mechanisms are poorly understood. Cu deficiency decreases superoxide dismutase activity and increases superoxide anions, which can interact with nitric oxide (NO), reducing the NO pool size. Given the role of NO as a developmental signaling molecule, we tested the hypothesis that low NO levels, secondary to Cu deficiency, represent a developmental challenge. Gestation day 8.5 embryos from Cu-adequate (Cu+) or Cu-deficient (Cu-) dams were cultured for 48 h in Cu+ or Cu- medium, respectively. We report that NO levels were low in conditioned medium from Cu-/Cu- embryos and yolk sacs, compared to Cu+/Cu+ controls under basal conditions and with NO synthase (NOS) agonists. The low NO production was associated with low endothelial NOS phosphorylation at serine 1177 and cyclic guanosine-3′,5′-monophosphate (cGMP) concentrations in the Cu-/Cu- group. The altered NO levels in Cu-deficient embryos are functionally significant, as the administration of the NO donor DETA/NONOate increased cGMP and ameliorated embryo and yolk sac abnormalities. These data support the concept that Cu deficiency limits NO availability and alters NO-dependent signaling, which contributes to abnormal embryo and yolk sac development.

Original languageEnglish (US)
Pages (from-to)1639-1648
Number of pages10
JournalFree Radical Biology and Medicine
Volume43
Issue number12
DOIs
StatePublished - Dec 15 2007

Fingerprint

Copper
Nitric Oxide
Embryonic Structures
Yolk Sac
Guanosine Monophosphate
Nitric Oxide Synthase
Phosphorylation
Nitric Oxide Donors
Conditioned Culture Medium
Superoxides
Serine
Dams
Superoxide Dismutase
Blood Vessels
Brain
Availability
Pregnancy
Molecules

Keywords

  • Copper deficiency
  • Cyclic GMP
  • Embryo development
  • Free radicals
  • Nitric oxide
  • Nutrition
  • Oxidative stress
  • Pregnancy
  • Superoxide dismutase
  • Yolk sac

ASJC Scopus subject areas

  • Medicine(all)
  • Toxicology
  • Clinical Biochemistry

Cite this

Low nitric oxide : a key factor underlying copper-deficiency teratogenicity. / Yang, Soo Jin; Keen, Carl L; Lanoue, Louise; Rucker, Robert B.; Uriu-Adams, Janet Y.

In: Free Radical Biology and Medicine, Vol. 43, No. 12, 15.12.2007, p. 1639-1648.

Research output: Contribution to journalArticle

Yang, Soo Jin ; Keen, Carl L ; Lanoue, Louise ; Rucker, Robert B. ; Uriu-Adams, Janet Y. / Low nitric oxide : a key factor underlying copper-deficiency teratogenicity. In: Free Radical Biology and Medicine. 2007 ; Vol. 43, No. 12. pp. 1639-1648.
@article{696ca5eed52f42e6a8739fefad80bdcb,
title = "Low nitric oxide: a key factor underlying copper-deficiency teratogenicity",
abstract = "Copper (Cu)-deficiency-induced teratogenicity is characterized by major cardiac, brain, and vascular anomalies; however, the underlying mechanisms are poorly understood. Cu deficiency decreases superoxide dismutase activity and increases superoxide anions, which can interact with nitric oxide (NO), reducing the NO pool size. Given the role of NO as a developmental signaling molecule, we tested the hypothesis that low NO levels, secondary to Cu deficiency, represent a developmental challenge. Gestation day 8.5 embryos from Cu-adequate (Cu+) or Cu-deficient (Cu-) dams were cultured for 48 h in Cu+ or Cu- medium, respectively. We report that NO levels were low in conditioned medium from Cu-/Cu- embryos and yolk sacs, compared to Cu+/Cu+ controls under basal conditions and with NO synthase (NOS) agonists. The low NO production was associated with low endothelial NOS phosphorylation at serine 1177 and cyclic guanosine-3′,5′-monophosphate (cGMP) concentrations in the Cu-/Cu- group. The altered NO levels in Cu-deficient embryos are functionally significant, as the administration of the NO donor DETA/NONOate increased cGMP and ameliorated embryo and yolk sac abnormalities. These data support the concept that Cu deficiency limits NO availability and alters NO-dependent signaling, which contributes to abnormal embryo and yolk sac development.",
keywords = "Copper deficiency, Cyclic GMP, Embryo development, Free radicals, Nitric oxide, Nutrition, Oxidative stress, Pregnancy, Superoxide dismutase, Yolk sac",
author = "Yang, {Soo Jin} and Keen, {Carl L} and Louise Lanoue and Rucker, {Robert B.} and Uriu-Adams, {Janet Y.}",
year = "2007",
month = "12",
day = "15",
doi = "10.1016/j.freeradbiomed.2007.08.031",
language = "English (US)",
volume = "43",
pages = "1639--1648",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Low nitric oxide

T2 - a key factor underlying copper-deficiency teratogenicity

AU - Yang, Soo Jin

AU - Keen, Carl L

AU - Lanoue, Louise

AU - Rucker, Robert B.

AU - Uriu-Adams, Janet Y.

PY - 2007/12/15

Y1 - 2007/12/15

N2 - Copper (Cu)-deficiency-induced teratogenicity is characterized by major cardiac, brain, and vascular anomalies; however, the underlying mechanisms are poorly understood. Cu deficiency decreases superoxide dismutase activity and increases superoxide anions, which can interact with nitric oxide (NO), reducing the NO pool size. Given the role of NO as a developmental signaling molecule, we tested the hypothesis that low NO levels, secondary to Cu deficiency, represent a developmental challenge. Gestation day 8.5 embryos from Cu-adequate (Cu+) or Cu-deficient (Cu-) dams were cultured for 48 h in Cu+ or Cu- medium, respectively. We report that NO levels were low in conditioned medium from Cu-/Cu- embryos and yolk sacs, compared to Cu+/Cu+ controls under basal conditions and with NO synthase (NOS) agonists. The low NO production was associated with low endothelial NOS phosphorylation at serine 1177 and cyclic guanosine-3′,5′-monophosphate (cGMP) concentrations in the Cu-/Cu- group. The altered NO levels in Cu-deficient embryos are functionally significant, as the administration of the NO donor DETA/NONOate increased cGMP and ameliorated embryo and yolk sac abnormalities. These data support the concept that Cu deficiency limits NO availability and alters NO-dependent signaling, which contributes to abnormal embryo and yolk sac development.

AB - Copper (Cu)-deficiency-induced teratogenicity is characterized by major cardiac, brain, and vascular anomalies; however, the underlying mechanisms are poorly understood. Cu deficiency decreases superoxide dismutase activity and increases superoxide anions, which can interact with nitric oxide (NO), reducing the NO pool size. Given the role of NO as a developmental signaling molecule, we tested the hypothesis that low NO levels, secondary to Cu deficiency, represent a developmental challenge. Gestation day 8.5 embryos from Cu-adequate (Cu+) or Cu-deficient (Cu-) dams were cultured for 48 h in Cu+ or Cu- medium, respectively. We report that NO levels were low in conditioned medium from Cu-/Cu- embryos and yolk sacs, compared to Cu+/Cu+ controls under basal conditions and with NO synthase (NOS) agonists. The low NO production was associated with low endothelial NOS phosphorylation at serine 1177 and cyclic guanosine-3′,5′-monophosphate (cGMP) concentrations in the Cu-/Cu- group. The altered NO levels in Cu-deficient embryos are functionally significant, as the administration of the NO donor DETA/NONOate increased cGMP and ameliorated embryo and yolk sac abnormalities. These data support the concept that Cu deficiency limits NO availability and alters NO-dependent signaling, which contributes to abnormal embryo and yolk sac development.

KW - Copper deficiency

KW - Cyclic GMP

KW - Embryo development

KW - Free radicals

KW - Nitric oxide

KW - Nutrition

KW - Oxidative stress

KW - Pregnancy

KW - Superoxide dismutase

KW - Yolk sac

UR - http://www.scopus.com/inward/record.url?scp=36248999362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36248999362&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2007.08.031

DO - 10.1016/j.freeradbiomed.2007.08.031

M3 - Article

C2 - 18037129

AN - SCOPUS:36248999362

VL - 43

SP - 1639

EP - 1648

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 12

ER -